植物多酚与肠道微生物群的相互作用及其对代谢性疾病影响的研究进展

摘要/Abstract

摘要： 摘要：肠道微生物群参与胰岛素抵抗、高血糖、血脂异常、中心性肥胖和高血压等组成的代谢综合征的发展，进一步导致代谢性疾病的发生。而植物多酚可以促进肠道微生物群中有益菌的生长，间接减少致病菌的数量。并且肠道微生物群能够将高分子量的植物多酚代谢为更具生物活性的代谢物以提高其生物利用度。本文综述了植物多酚与肠道微生物群两者之间的相互作用及其对代谢性疾病的影响，为植物多酚的利用提供参考。

关键词: 关键词：植物多酚, 肠道微生物群, 代谢性疾病, 代谢综合征, 肥胖

Abstract: Abstract: Intestinal microflora is involved in the development of metabolic syndrome, which is composed of insulin resistance, hyperglycemia, dyslipidemia, central obesity and hypertension. Plant polyphenols can promote the growth of beneficial bacteria in intestinal microflora and indirectly reduce the number of pathogenic bacteria. Moreover, intestinal microbiota can metabolize high molecular weight plant polyphenols into more bioactive metabolites to improve their bioavailability. In this paper, the interaction between plant polyphenols and intestinal microflora and their effects on metabolic diseases are reviewed, which can provide reference for the utilization of plant polyphenols.

Key words: Keywords: plant polyphenols, intestinal microflora, metabolic diseases, metabolic syndrome, obesity

中图分类号:

TS201.3

赵媚常凌宋泽和贺喜. 植物多酚与肠道微生物群的相互作用及其对代谢性疾病影响的研究进展[J]. 食品科学, 0, (): 0-0.

参考文献

[1] Engin A.The definition and prevalence of obesity and metabolic syndrome[M]//Obesity and Lipotoxicity. Springer, Cham, 2017: 1-17. [2] Karim N, Jia Z, Zheng X, et al.A recent review of citrus flavanone naringenin on metabolic diseases and its potential sources for high yield-production[J]. Trends in Food Science & Technology, 2018, 79: 35-54.[J].Trends in Food Science & Technology, 2018, 79(9):35-54 [3] Dao M C, Clément K.Gut microbiota and obesity: Concepts relevant to clinical care[J]. European journal of internal medicine, 2018, 48: 18-24.[J].European Journal of Internal Medicine, 2018, 48(2):18-24 [4]González‐Sarrías A, Romo‐Vaquero M, García‐Villalba R, et al.The Endotoxemia Marker Lipopolysaccharide‐Binding Protein is Reduced in Overweight‐Obese Subjects Consuming Pomegranate Extract by Modulating the Gut Microbiota: A Randomized Clinical Trial[J].Molecular nutrition & food research, 2018, 62(11):1800160- [5] Eid H M, Wright M L, Anil Kumar N V, et al.Significance of microbiota in obesity and metabolic diseases and the modulatory potential by medicinal plant and food ingredients[J]. Frontiers in pharmacology, 2017, 8: 387. [6]Cani P D, Van Hul M, Lefort C, et al.Microbial regulation of organismal energy homeostasis[J].Nature Metabolism, 2019, 1(1):34-46 [7]Canfora E E, Meex R C R, Venema K, et al.Gut microbial metabolites in obesity,NAFLD and T2DM[J].Nature Reviews Endocrinology, 2019, 15(5):261-273 [8] Al-Assal K, Martinez A C, Torrinhas R S, et al.Gut microbiota and obesity[J]. Clinical Nutrition Experimental, 2018, 20: 60-64. [9] Collins B, Hoffman J, Martinez K, et al.A polyphenol-rich fraction obtained from table grapes decreases adiposity, insulin resistance and markers of inflammation and impacts gut microbiota in high-fat-fed mice[J]. The Journal of nutritional biochemistry, 2016, 31: 150-165. [10] Danneskiold-Sams?e N B, Barros H D F Q, Santos R, et al.Interplay between food and gut microbiota in health and disease[J]. Food Research International, 2019, 115: 23-31. [11] Jiao X, Wang Y, Lin Y, et al.Blueberry polyphenols extract as a potential prebiotic with anti-obesity effects on C57BL/6 J mice by modulating the gut microbiota[J]. The Journal of nutritional biochemistry, 2019, 64: 88-100. [12]Saad M J A, Santos A, Prada P O.Linking gut microbiota and inflammation to obesity and insulin resistance[J].Physiology, 2016, 31(4):283-293 [13]Anhê F F, Varin T V, Le Barz M, et al.Gut microbiota dysbiosis in obesity-linked metabolic diseases and prebiotic potential of polyphenol-rich extracts[J].Current obesity reports, 2015, 4(4):389-400 [14] Carrera-Quintanar L, López Roa R I, Quintero-Fabián S, et al.Phytochemicals that influence gut microbiota as prophylactics and for the treatment of obesity and inflammatory diseases[J]. Mediators of inflammation, 2018, 2018. [15] Due?as M, Mu?oz-González I, Cueva C, et al.A survey of modulation of gut microbiota by dietary polyphenols[J]. BioMed research international, 2015, 2015. [16]Jamar G, Estadella D, Pisani L P.Contribution of anthocyanin‐rich foods in obesity control through gut microbiota interactions[J].BioFactors, 2017, 43(4):507-516 [17] Scalbert A.Phenol-Explorer: database on polyphenol content in foods[J]. 2009. [18] Hussain M B, Hassan S, Waheed M, et al.Bioavailability and Metabolic Pathway of Phenolic Compounds[M]//Plant Physiological Aspects of Phenolic Compounds. IntechOpen, 2019. [19] Chen L, Cao H, Xiao J.Polyphenols: Absorption, bioavailability, and metabolomics[M]//Polyphenols: Properties, Recovery, and Applications. Woodhead Publishing, 2018: 45-67. [20]Cassidy A, Minihane A M.The role of metabolism (and the microbiome) in defining the clinical efficacy of dietary flavonoids[J].The American journal of clinical nutrition, 2017, 105(1):10-22 [21]Choy Y Y, Quifer-Rada P, Holstege D M, et al.Phenolic metabolites and substantial microbiome changes in pig feces by ingesting grape seed proanthocyanidins[J].Food & function, 2014, 5(9):2298-2308 [22]Lipińska L, Klewicka E, Sójka M.The structure,occurrence and biological activity of ellagitannins: a general review[J].Acta Scientiarum Polonorum Technologia Alimentaria, 2014, 13(3):289-299 [23]Selma M V, Beltrán D, García-Villalba R, et al.Description of urolithin production capacity from ellagic acid of two human intestinal Gordonibacter species[J].Food & function, 2014, 5(8):1779-1784 [24]Mosele J I, Macià A, Motilva M J.Metabolic and microbial modulation of the large intestine ecosystem by non-absorbed diet phenolic compounds: a review[J].Molecules, 2015, 20(9):17429-17468 [25]Bode L M, Bunzel D, Huch M, et al.In vivo and in vitro metabolism of trans-resveratrol by human gut microbiota[J].The American journal of clinical nutrition, 2013, 97(2):295-309 [26]Hostetler G L, Ralston R A, Schwartz S J.Flavones: Food sources,bioavailability,metabolism,and bioactivity[J].Advances in nutrition, 2017, 8(3):423-435 [27]Jiang N, Doseff A I, Grotewold E.Flavones: from biosynthesis to health benefits[J].Plants, 2016, 5(2):27- [28] Tundis R, Acquaviva R, Bonesi M, et al.Citrus Flavanones[J]. Handbook of Dietary Phytochemicals, 2019: 1-30. [29]Barreca D, Gattuso G, Bellocco E, et al.Flavanones: Citrus phytochemical with health‐promoting properties[J].BioFactors, 2017, 43(4):495-506 [30]Testai L, Calderone V.Nutraceutical value of citrus flavanones and their implications in cardiovascular disease[J].Nutrients, 2017, 9(5):502- [31] Martinez V, Mestre T C, Rubio F, et al.Accumulation of flavonols over hydroxycinnamic acids favors oxidative damage protection under abiotic stress[J]. Frontiers in plant science, 2016, 7: 838. [32] Scarano A, Butelli E, De Santis S, et al.Combined dietary anthocyanins, flavonols, and stilbenoids alleviate inflammatory bowel disease symptoms in mice[J]. Frontiers in nutrition, 2018, 4: 75. [33] Kamiloglu S, Tomas M, Capanoglu E.Dietary Flavonols and O-Glycosides[J]. Handbook of Dietary Phytochemicals, 2019: 1-40. [34]Mena P, Bresciani L, Brindani N, et al.Phenyl-γ-valerolactones and phenylvaleric acids,the main colonic metabolites of flavan-3-ols: Synthesis,analysis,bioavailability,and bioactivity[J].Natural product reports, 2019, 36(5):714-752 [35] Mena P, de Llano D G, Brindani N, et al.5-(3′, 4′-Dihydroxyphenyl)-γ-valerolactone and its sulphate conjugates, representative circulating metabolites of flavan-3-ols, exhibit anti-adhesive activity against uropathogenic Escherichia coli in bladder epithelial cells[J]. Journal of Functional Foods, 2017, 29: 275-280. [36] Fayeulle N, Vallverdu-Queralt A, Meudec E, et al.Characterization of new flavan-3-ol derivatives in fermented cocoa beans[J]. Food chemistry, 2018, 259: 207-212. [37]Khoo H E, Azlan A, Tang S T, et al.Anthocyanidins and anthocyanins: colored pigments as food,pharmaceutical ingredients,and the potential health benefits[J].Food & nutrition research, 2017, 61(1):1361779- [38] Ali H M, Almagribi W, Al-Rashidi M N.Antiradical and reductant activities of anthocyanidins and anthocyanins, structure–activity relationship and synthesis[J]. Food Chemistry, 2016, 194: 1275-1282. [39]Mudd A M, Gu T, Munagala R, et al.Chemoprevention of colorectal cancer by Anthocyanidins and mitigation of metabolic shifts induced by dysbiosis of the gut microbiome[J].Cancer Prevention Research, 2020, 13(1):41-52 [40]Yu J, Bi X, Yu B, et al.Isoflavones: anti-inflammatory benefit and possible caveats[J].Nutrients, 2016, 8(6):361- [41]Zaheer K, Humayoun Akhtar M.An updated review of dietary isoflavones: Nutrition,processing,bioavailability and impacts on human health[J].Critical reviews in food science and nutrition, 2017, 57(6):1280-1293 [42]Umeno A, Horie M, Murotomi K, et al.Antioxidative and antidiabetic effects of natural polyphenols and isoflavones[J].Molecules, 2016, 21(6):708- [43] Bento-Silva A, Koistinen V M, Mena P, et al.Factors affecting intake, metabolism and health benefits of phenolic acids: do we understand individual variability?[J]. European journal of nutrition, 2019: 1-19. [44] de Camargo A C, Regitano-d' Arce M A B, Rasera G B, et al.Phenolic acids and flavonoids of peanut by-products: Antioxidant capacity and antimicrobial effects[J]. Food chemistry, 2017, 237: 538-544. [45]Szwajgier D, Borowiec K, Pustelniak K.The neuroprotective effects of phenolic acids: molecular mechanism of action[J].Nutrients, 2017, 9(5):477- [46]Ismail T, Calcabrini C, Diaz A R, et al.Ellagitannins in cancer chemoprevention and therapy[J].Toxins, 2016, 8(5):151- [47]Rasines-Perea Z, Jacquet R, Jourdes M, et al.Ellagitannins and Flavano-Ellagitannins: Red Wines Tendency in Different Areas,Barrel Origin and Ageing Time in Barrel and Bottle[J].Biomolecules, 2019, 9(8):316- [48]Aguilar-Zárate P, Wong-Paz J E, Buenrostro-Figueroa J J, et al.Ellagitannins: bioavailability,purification and biotechnological degradation[J].Mini reviews in medicinal chemistry, 2018, 18(15):1244-1252 [49]Amalraj A, Pius A, Gopi S, et al.Biological activities of curcuminoids,other biomolecules from turmeric and their derivatives–A review[J].Journal of traditional and complementary medicine, 2017, 7(2):205-233 [50] Panahi Y, Khalili N, Sahebi E, et al.Curcuminoids modify lipid profile in type 2 diabetes mellitus: a randomized controlled trial[J]. Complementary therapies in medicine, 2017, 33: 1-5. [51]Panahi Y, Alishiri G H, Parvin S, et al.Mitigation of systemic oxidative stress by curcuminoids in osteoarthritis: results of a randomized controlled trial[J].Journal of dietary supplements, 2016, 13(2):209-220 [52]Berman A Y, Motechin R A, Wiesenfeld M Y, et al.The therapeutic potential of resveratrol: a review of clinical trials[J].NPJ precision oncology, 2017, 1(1):1-9 [53]Bonnefont-Rousselot D.Resveratrol and cardiovascular diseases[J].Nutrients, 2016, 8(5):250- [54] Varoni E M, Lo Faro A F, Sharifi-Rad J, et al.Anticancer molecular mechanisms of resveratrol[J]. Frontiers in nutrition, 2016, 3: 8. [55]Selma M V, Espin J C, Tomas-Barberan F A.Interaction between phenolics and gut microbiota: role in human health[J].Journal of agricultural and food chemistry, 2009, 57(15):6485-6501 [56]Ozdal T, Sela D A, Xiao J, et al.The reciprocal interactions between polyphenols and gut microbiota and effects on bioaccessibility[J].Nutrients, 2016, 8(2):78- [57]Krga I, Milenkovic D.Anthocyanins: from sources and bioavailability to cardiovascular-health benefits and molecular mechanisms of action[J].Journal of agricultural and food chemistry, 2019, 67(7):1771-1783 [58]Etxeberria U, Ferna?ndez-Quintela A, Milagro F I, et al.Impact of polyphenols and polyphenol-rich dietary sources on gut microbiota composition[J].Journal of agricultural and food chemistry, 2013, 61(40):9517-9533 [59]Karlsson F H, Tremaroli V, Nookaew I, et al.Gut metagenome in European women with normal,impaired and diabetic glucose control[J].Nature, 2013, 498(7452):99-103 [60]Rowland I, Gibson G, Heinken A, et al.Gut microbiota functions: metabolism of nutrients and other food components[J].European journal of nutrition, 2018, 57(1):1-24 [61] ?ak-Go??b A, Koce?ak P, Aptekorz M, et al.Gut microbiota, microinflammation, metabolic profile, and zonulin concentration in obese and normal weight subjects[J]. International journal of endocrinology, 2013, 2013. [62]Furet J P, Kong L C, Tap J, et al.Differential adaptation of human gut microbiota to bariatric surgery–induced weight loss: links with metabolic and low-grade inflammation markers[J].Diabetes, 2010, 59(12):3049-3057 [63] Maya-Lucas O, Murugesan S, Nirmalkar K, et al.The gut microbiome of Mexican children affected by obesity[J]. Anaerobe, 2019, 55: 11-23. [64]Fleissner C K, Huebel N, El-Bary M M A, et al.Absence of intestinal microbiota does not protect mice from diet-induced obesity[J].British Journal of Nutrition, 2010, 104(6):919-929 [65]B?ckhed F, Ding H, Wang T, et al.The gut microbiota as an environmental factor that regulates fat storage[J].Proceedings of the national academy of sciences, 2004, 101(44):15718-15723 [66]Vaarala O, Atkinson M A, Neu J.The “perfect storm” for type 1 diabetes: the complex interplay between intestinal microbiota,gut permeability,and mucosal immunity[J].Diabetes, 2008, 57(10):2555-2562 [67]Giongo A, Gano K A, Crabb D B, et al.Toward defining the autoimmune microbiome for type 1 diabetes[J].The ISME journal, 2011, 5(1):82-91 [68]Murri M, Leiva I, Gomez-Zumaquero J M, et al.Gut microbiota in children with type 1 diabetes differs from that in healthy children: a case-control study[J].BMC medicine, 2013, 11(1):46- [69]Leiva-Gea I, Sánchez-Alcoholado L, Martín-Tejedor B, et al.Gut microbiota differs in composition and functionality between children with type 1 diabetes and MODY2 and healthy control subjects: a case-control study[J].Diabetes Care, 2018, 41(11):2385-2395 [70]Brugman S, Klatter F A, Visser J T J, et al.Antibiotic treatment partially protects against type 1 diabetes in the Bio-Breeding diabetes-prone ratIs the gut flora involved in the development of type 1 diabetes?[J].Diabetologia, 2006, 49(9):2105-2108 [71] Larsen N, Vogensen F K, Van Den Berg F W J, et al.Gut microbiota in human adults with type 2 diabetes differs from non-diabetic adults[J]. PloS one, 2010, 5(2). [72]Qin J, Li Y, Cai Z, et al.A metagenome-wide association study of gut microbiota in type 2 diabetes[J].Nature, 2012, 490(7418):55-60 [73]Wang Z, Tang W H W, Buffa J A, et al.Prognostic value of choline and betaine depends on intestinal microbiota-generated metabolite trimethylamine-N-oxide[J].European heart journal, 2014, 35(14):904-910 [74]Wang Z, Klipfell E, Bennett B J, et al.Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease[J].Nature, 2011, 472(7341):57-63 [75]Yang T, Santisteban M M, Rodriguez V, et al.Gut dysbiosis is linked to hypertension[J].Hypertension, 2015, 65(6):1331-1340 [76] Jiang W, Wu N, Wang X, et al.Dysbiosis gut microbiota associated with inflammation and impaired mucosal immune function in intestine of humans with non-alcoholic fatty liver disease[J]. Scientific reports, 2015, 5: 8096. [77]Huttenhower C, Gevers D, Knight R, et al.Structure,function and diversity of the healthy human microbiome[J].nature, 2012, 486(7402):207- [78]Due?as M, Cueva C, Mu?oz-González I, et al.Studies on modulation of gut microbiota by wine polyphenols: from isolated cultures to omic approaches[J].Antioxidants, 2015, 4(1):1-21 [79]Moco S, Martin F P J, Rezzi S.Metabolomics view on gut microbiome modulation by polyphenol-rich foods[J].Journal of proteome research, 2012, 11(10):4781-4790 [80] Tao J, Duan J, Jiang S, et al.Biotransformation and metabolic profile of buddleoside with human intestinal microflora by ultrahigh-performance liquid chromatography coupled to hybrid linear ion trap/orbitrap mass spectrometer[J]. Journal of Chromatography B, 2016, 1025: 7-15. [81] Chen Y, Li Q, Zhao T, et al.Biotransformation and metabolism of three mulberry anthocyanin monomers by rat gut microflora[J]. Food chemistry, 2017, 237: 887-894. [82] Mayta-Apaza A C, Pottgen E, De Bodt J, et al.Impact of tart cherries polyphenols on the human gut microbiota and phenolic metabolites in vitro and in vivo[J]. The Journal of nutritional biochemistry, 2018, 59: 160-172. [83] Gowd V, Bao T, Chen W.Antioxidant potential and phenolic profile of blackberry anthocyanin extract followed by human gut microbiota fermentation[J]. Food research international, 2019, 120: 523-533. [84]Larrosa M, García-Conesa M T, Espín J C, et al.Ellagitannins,ellagic acid and vascular health[J].Molecular aspects of medicine, 2010, 31(6):513-539 [85]Selma M V, González-Sarrías A, Salas-Salvadó J, et al.The gut microbiota metabolism of pomegranate or walnut ellagitannins yields two urolithin-metabotypes that correlate with cardiometabolic risk biomarkers: Comparison between normoweight,overweight-obesity and metabolic syndrome[J].Clinical Nutrition, 2018, 37(3):897-905 [86]Beltrán D, Romo-Vaquero M, Espín J C, et al.Ellagibacter isourolithinifaciens gennov.,sp. nov.,a new member of the family Eggerthellaceae,isolated from human gut[J].International journal of systematic and evolutionary microbiology, 2018, 68(5):1707-1712 [87] Theilmann M C, Goh Y J, Nielsen K F, et al.Lactobacillus acidophilus metabolizes dietary plant glucosides and externalizes their bioactive phytochemicals[J]. MBio, 2017, 8(6). [88]Liu Y W, Liong M T, Tsai Y C.New perspectives of Lactobacillus plantarum as a probiotic: The gut-heart-brain axis[J].Journal of Microbiology, 2018, 56(9):601-613 [89] Wang J, Ji H, Wang S, et al.Probiotic Lactobacillus plantarum promotes intestinal barrier function by strengthening the epithelium and modulating gut microbiota[J]. Frontiers in microbiology, 2018, 9: 1953. [90]Barroso E, Van de Wiele T, Jime?nez-Giro?n A, et al.Lactobacillus plantarum IFPL935 impacts colonic metabolism in a simulator of the human gut microbiota during feeding with red wine polyphenols[J].Applied microbiology and biotechnology, 2014, 98(15):6805-6815 [91] Chen M Y, Shao L, Zhang W, et al.Metabolic analysis of Panax notoginseng saponins with gut microbiota-mediated biotransformation by HPLC-DAD-Q-TOF-MS/MS[J]. Journal of pharmaceutical and biomedical analysis, 2018, 150: 199-207. [92]Duda-Chodak A, Tarko T, Satora P, et al.Interaction of dietary compounds,especially polyphenols,with the intestinal microbiota: a review[J].European journal of nutrition, 2015, 54(3):325-341 [93] Gowd V, Jia Z, Chen W.Anthocyanins as promising molecules and dietary bioactive components against diabetes–A review of recent advances[J]. Trends in Food Science & Technology, 2017, 68: 1-13. [94] Chen W, Su H, Xu Y, et al.Protective effect of wild raspberry (Rubus hirsutus Thunb.) extract against acrylamide-induced oxidative damage is potentiated after simulated gastrointestinal digestion[J]. Food Chemistry, 2016, 196: 943-952. [95]Roopchand D E, Carmody R N, Kuhn P, et al.Dietary polyphenols promote growth of the gut bacterium Akkermansia muciniphila and attenuate high-fat diet–induced metabolic syndrome[J].Diabetes, 2015, 64(8):2847-2858 [96]Anhê F F, Roy D, Pilon G, et al.A polyphenol-rich cranberry extract protects from diet-induced obesity,insulin resistance and intestinal inflammation in association with increased Akkermansia spppopulation in the gut microbiota of mice[J].Gut, 2015, 64(6):872-883 [97] Zheng S, Huang K, Zhao C, et al.Procyanidin attenuates weight gain and modifies the gut microbiota in high fat diet induced obese mice[J]. Journal of functional foods, 2018, 49: 362-368. [98] Masumoto S, Terao A, Yamamoto Y, et al.Non-absorbable apple procyanidins prevent obesity associated with gut microbial and metabolomic changes[J]. Scientific reports, 2016, 6: 31208. [99]Qiao Y, Sun J, Xia S, et al.Effects of resveratrol on gut microbiota and fat storage in a mouse model with high-fat-induced obesity[J].Food & function, 2014, 5(6):1241-1249 [100]Etxeberria U, Arias N, Boqué N, et al.Reshaping faecal gut microbiota composition by the intake of trans-resveratrol and quercetin in high-fat sucrose diet-fed rats[J].The Journal of nutritional biochemistry, 2015, 26(6):651-660 [101]Li Y, Li J, Su Q, et al.Sinapine reduces non-alcoholic fatty liver disease in mice by modulating the composition of the gut microbiota[J].Food & function, 2019, 10(6):3637-3649 [102]Chen T, Liu A B, Sun S, et al.Green Tea Polyphenols Modify the Gut Microbiome in dbdb Mice as Co‐Abundance Groups Correlating with the Blood Glucose Lowering Effect[J].Molecular nutrition & food research, 2019, 63(8):1801064- [103] Cheng M, Zhang X, Miao Y, et al.The modulatory effect of (-)-epigallocatechin 3-O-(3-O-methyl) gallate (EGCG3 ″Me) on intestinal microbiota of high fat diet-induced obesity mice model[J]. Food Research International, 2017, 92: 9-16. [104] Kuhn P, Kalariya H M, Poulev A, et al.Grape polyphenols reduce gut-localized reactive oxygen species associated with the development of metabolic syndrome in mice[J]. PloS one, 2018, 13(10). [105] Remely M, Ferk F, Sterneder S, et al.EGCG prevents high fat diet-induced changes in gut microbiota, decreases of DNA strand breaks, and changes in expression and DNA methylation of Dnmt1 and MLH1 in C57BL/6J male mice[J]. Oxidative medicine and cellular longevity, 2017, 2017. [106] Zhang X, Shen D, Fang Z, et al.Human gut microbiota changes reveal the progression of glucose intolerance[J]. PloS one, 2013, 8(8). [107]Ashley D, Marasini D, Brownmiller C, et al.Impact of grain sorghum polyphenols on microbiota of normal weight and overweightobese subjects during in vitro fecal fermentation[J].Nutrients, 2019, 11(2):217- [108]Lima A C D, Cecatti C, Fidélix M P, et al.Effect of daily consumption of orange juice on the levels of blood glucose,lipids,and gut microbiota metabolites: Controlled clinical trials[J].Journal of medicinal food, 2019, 22(2):202-210